FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Sherman

Research Profile

Disorders

Living Beings

Papillomaviridae

Geographic Areas

Concepts & Ideas

Chemicals & Drugs

DNA, Viral

Procedures

Anatomy

Cervix Uteri

Co-author Network

Publications

TOP 3
Louise A Brinton; David E Cohn; William T Creasman; Levi S Downs; Ashley S Felix; D Scott McMeekin; Richard G Moore; David Mutch; Mark E Sherman; Robert A Soslow; Joan L Walker; Richard J Zaino
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.
Rayna K Matsuno; Ruth M Pfeiffer; Charles Platz; Mark E Sherman; Kala Visvanathan; Marc T Goodman; Brenda Y Hernandez; David Horio; Olga B Ioffe; Charles F Lynch; Sean Altekruse; William F Anderson
Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository.
Jessica M Faupel-Badger; Foteini Hassiotou; Carlito B Lebrilla; Karin B Michels; Julie R Palmer; Pepper Schedin; Kathleen F Arcaro; Jane J Balkam; A Heather Eliassen; Alison M Stuebe; Christine J Watson; Mark E Sherman
Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Sherman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Louise A Brinton; David E Cohn; William T Creasman; Levi S Downs; Ashley S Felix; D Scott McMeekin; Richard G Moore; David Mutch; Mark E Sherman; Robert A Soslow; Joan L Walker; Richard J Zaino
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.
Gynecologic oncology 2013;129(2):277-84.
2013: Rayna K Matsuno; Ruth M Pfeiffer; Charles Platz; Mark E Sherman; Kala Visvanathan; Marc T Goodman; Brenda Y Hernandez; David Horio; Olga B Ioffe; Charles F Lynch; Sean Altekruse; William F Anderson
Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository.
Cancer causes & control : CCC 2013;24(4):749-57.
2013: Jessica M Faupel-Badger; Foteini Hassiotou; Carlito B Lebrilla; Karin B Michels; Julie R Palmer; Pepper Schedin; Kathleen F Arcaro; Jane J Balkam; A Heather Eliassen; Alison M Stuebe; Christine J Watson; Mark E Sherman
Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop.
Journal of the National Cancer Institute 2013;105(3):166-74.
2013: Xiaohong Rose Yang; Louise A Brinton; Roni T Falk; Jonine D Figueroa; Montserrat Garcia-Closas; Stephen M Hewitt; Jolanta Lissowska; Beata Peplonska; Ruth M Pfeiffer; Mark E Sherman
Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.
Breast cancer research and treatment 2013;137(3):837-47.
2013: Jill Koshiol; Mark Schiffman; Mark E Sherman; Joan L Walker; Sophia S Wang; Richard A Allen; S Terence Dunn; Michael A Gold; Roy Zhang; Rosemary E Zuna; Nicolas Wentzensen
Reproducibility of linear array for human papillomavirus genotyping.
Journal of clinical microbiology 2013;51(2):625-8.
2013: Britton Trabert; Nicolas Wentzensen; Hannah P Yang; Albert Russell Hollenbeck; Yikyung Park; Mark E Sherman; Louise A Brinton
Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
International journal of cancer. Journal international du cancer 2013;132(2):417-26.
2012: Mark E Sherman; Nicolas Wentzensen; Hannah P Yang; Richard Guido; Phuong L Mai; Mark H Greene
New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research.
Gynecologic oncology 2012;127(3):645-50.
2012: Vikrant V Sahasrabuddhe; Mark E Sherman
Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality.
Journal of the National Cancer Institute 2012;104(22):1698-701.
2012: Megan A Murphy; Yikyung Park; Mark E Sherman; Britton Trabert; Louise A Brinton; Patricia Hartge; Albert Russell Hollenbeck; Hannah P Yang; Nicolas Wentzensen
Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.
Cancer causes & control : CCC 2012;23(11):1839-52.
2012: James V Lacey; Bryan Langholz; Douglas A Richesson; Brigitte M Ronnett; Brenda B Rush; Mark E Sherman; Danny J Carreon; Nilanjan Chatterjee; Victoria M Chia; Olga B Ioffe; Andrew G. Glass
Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan.
International journal of cancer. Journal international du cancer 2012;131(8):1921-9.
2012: Ana Cecilia Rodríguez; Mark Schiffman; Mark E Sherman; Diane Solomon; Sholom Wacholder; Li Cheung; Diego Guillén; Rolando Herrero; Allan Hildesheim; Martha Hutchinson; Jorge Morales; Mario Alfaro; Concepción Bratti; Robert D Burk
Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
International journal of cancer. Journal international du cancer 2012;131(8):1874-81.
2012: B Trabert; Nicolas Wentzensen; H P Yang; K N Danforth; Albert Russell Hollenbeck; Yikyung Park; Mark E Sherman; Louise A Brinton
Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study.
British journal of cancer 2012;107(7):1181-7.
2012: Mahboobeh Safaeian; Mark Schiffman; Mark E Sherman; Leen-Jan van Doorn; Sholom Wacholder; Nicolas Wentzensen; Mark Esser; Arpita Ghosh; Paula Gonzalez; Rolando Herrero; Troy Kemp; Shih-Wen Lin; Katie Matys; Ariane Meuree; Ligia A Pinto; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Allan Hildesheim
Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(9):1547-54.
2012: Hannah P Yang; Louise A Brinton; Patricia Hartge; Albert Russell Hollenbeck; Megan A Murphy; Yikyung Park; Joshua N Sampson; Mark E Sherman; Britton Trabert; Nicolas Wentzensen
Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study.
International journal of cancer. Journal international du cancer 2012;131(4):938-48.
2012: Aimée R Kreimer; Carolina Porras; Mark Schiffman; Mark E Sherman; Li Cheung; Franklin Demuth; Paula González; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Robert D Burk; Ana Cecilia Rodríguez
Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.
International journal of cancer. Journal international du cancer 2012;131(1):211-8.
2012: Carolina Porras; Ana Cecilia Rodríguez; Mario Alfaro; Robert D Burk; Rolando Herrero; Allan Hildesheim; Martha Hutchinson; Jorge Morales; Mark E Sherman; Diane Solomon; Sholom Wacholder; Nicolas Wentzensen; Mark Schiffman
Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
International journal of cancer. Journal international du cancer 2012;130(8):1879-87.
2012: Xiaohong Rose Yang; Hong Zhang; Louise Brinton; Roni T Falk; Jonine D Figueroa; Montserrat Garcia-Closas; Stephen M Hewitt; Jolanta Lissowska; Beata Peplonska; Ruth M Pfeiffer; Mark E Sherman
Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers.
Breast cancer research : BCR 2012;14(2):R64.
2012: Mahboobeh Safaeian; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Kai Yu; Laurie Burdette; Robert D Burk; STEPHEN CHANOCK; Paula Gonzalez; Rolando Herrero; Allan Hildesheim; Qizhai Li; Carolina Porras; Ana Cecilia Rodriguez; Sophia S Wang
Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
PloS one 2012;7(4):e33619.
2012: Hannah P Yang; Roy Zhang; Rosemary E Zuna; Richard A Allen; S Terence Dunn; Michael A Gold; Lisa M Landrum; Rodney Long; Katherine Moxley; Mark Schiffman; Mark E Sherman; Joan L Walker; Sophia S Wang; Nicolas Wentzensen
Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3.
PloS one 2012;7(1):e29051.
2011: Aimée R Kreimer; Douglas Lowy; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mark Schiffman; John T Schiller; John E Schussler; Mark E Sherman; Diane Solomon; Sholom Wacholder; Paula González; Rolando Herrero; Allan Hildesheim; Silvia Jiménez
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.
Journal of the National Cancer Institute 2011;103(19):1444-51.
2011: Rolando Herrero; Allan Hildesheim; Silvia Jiménez; Aimée R Kreimer; Douglas R Lowy; Carolina Porras; Wim Quint; Ana Cecilia Rodríguez; Mark Schiffman; John T Schiller; John E Schussler; Mark E Sherman; Diane Solomon; Sholom Wacholder; Paula González
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica.
Cancer discovery 2011;1(5):408-19.
2011: Sarah E Coseo; Lori E Dodd; Paula Gonzalez; Rolando Herrero; Allan Hildesheim; Silvia Jimenez; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mahboobeh Safaeian; Mark Schiffman; Mark E Sherman; Diane Solomon; Leen-Jan van Doorn; Sholom Wacholder; Catherine Bougelet
Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
Sexually transmitted diseases 2011;38(10):976-82.
2011: Mark Schiffman; David R Scott; Mark E Sherman; Sholom Wacholder; Nicolas Wentzensen; Philip E Castle; Andrew G. Glass; Peter Kirk; Attila T Lorincz; Brenda B Rush; Greg Rydzak; Julie Buckland; Robert D Burk
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(7):1398-409.
2011: Hannah P Yang; Gretchen L Gierach; Kim N Danforth; Mark E Sherman; Yikyung Park; Nicolas Wentzensen; Albert Russell Hollenbeck; Arthur Schatzkin; Louise A Brinton
Alcohol and endometrial cancer risk in the NIH-AARP diet and health study.
International journal of cancer. Journal international du cancer 2011;128(12):2953-61.
2011: Hannah P Yang; Amanda Black; Roni T Falk; Louise A Brinton; Nancy Potischman; Nicolas Wentzensen; Jessica M Faupel-Badger; Mark E Sherman
Association of serum sex steroid hormone hemodilution and body mass index among healthy postmenopausal women.
Annals of epidemiology 2011;21(6):466-71.
2011: Anil K Chaturvedi; Hormuzd A Katki; Allan Hildesheim; Ana Cecilia Rodríguez; Wim Quint; Mark Schiffman; Leen-Jan van Doorn; Carolina Porras; Sholom Wacholder; Paula Gonzalez; Mark E Sherman; Rolando Herrero
Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.
The Journal of infectious diseases 2011;203(7):910-20.
2011: Kristine ERICA Johnson; Andrew D Redd; Thomas C Quinn; Aleisha N Collinson-Streng; Toby Cornish; Xiangrong Kong; Rajni Sharma; Aaron A R Tobian; Benjamin Tsai; Mark E Sherman; Godfrey Kigozi; David Serwadda; Maria J Wawer; Ronald H Gray
Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda.
The Journal of infectious diseases 2011;203(5):602-9.
2011: Sarah J Nyante; Amanda Black; Aimée R Kreimer; Máire A Duggan; Joseph D Carreon; Bruce Kessel; Saundra S Buys; Lawrence R Ragard; Karen A Johnson; Barbara K Dunn; Lois Lamerato; John M Commins; Christine D Berg; Mark E Sherman
Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.
Gynecologic oncology 2011;120(3):474-9.
2011: James V Lacey; Hannah Yang; Mia M Gaudet; Alison Dunning; Jolanta Lissowska; Mark E Sherman; Beata Peplonska; Louise A Brinton; Catherine S Healey; Shahana Ahmed; Paul Pharoah; Douglas Easton; STEPHEN CHANOCK; Montserrat Garcia-Closas
Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study.
Gynecologic oncology 2011;120(2):167-73.
2011: Sarah J Nyante; Beata Peplonska; Ruth M Pfeiffer; Mark E Sherman; Barbara K Vonderhaar; Abegail A Andaya; Louise A Brinton; STEPHEN CHANOCK; Roni T Falk; Jessica M Faupel-Badger; Montserrat Garcia-Closas; Mia M. Gaudet; Jolanta Lissowska; Jonine D Figueroa
Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.
Breast cancer research : BCR 2011;13(2):R42.
2011: Jesus Gonzalez Bosquet; Jacob Calcei; Jun S Wei; Montserrat Garcia-Closas; Mark E Sherman; Stephen Hewitt; Joseph Vockley; Jolanta Lissowska; Hannah P Yang; Javed Khan; STEPHEN CHANOCK
Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers.
PloS one 2011;6(1):e14522.
2010: Gretchen L Gierach; Louise A Brinton; Mark E Sherman
Lobular involution, mammographic density, and breast cancer risk: visualizing the future?
Journal of the National Cancer Institute 2010;102(22):1685-7.
2010: Mahboobeh Safaeian; Carolina Porras; Mark Schiffman; Ana Cecilia Rodriguez; Sholom Wacholder; Paula Gonzalez; Wim Quint; Leen-Jan van Doorn; Mark E Sherman; Valérie Xhenseval; Rolando Herrero; Allan Hildesheim
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
Journal of the National Cancer Institute 2010;102(21):1653-62.
2010: Sarah Coseo; Carolina Porras; Allan Hildesheim; Ana Cecilia Rodriguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Paula Gonzalez; Sophia S Wang; Mark E Sherman; Silvia Jimenez; Diane Solomon; Catherine Bougelet; Leen-Jan van Doorn; Wim Quint; Mahboobeh Safaeian
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Sexually transmitted diseases 2010;37(11):706-14.
2010: Jessica M Faupel-Badger; Mark E Sherman; Montserrat Garcia-Closas; Mia M. Gaudet; Roni T Falk; A Andaya; Ruth M Pfeiffer; Xiaohong Rose Yang; Jolanta Lissowska; Louise A Brinton; Beata Peplonska; Barbara K Vonderhaar; Jonine D Figueroa
Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland.
British journal of cancer 2010;103(7):1097-102.
2010: Jonine D Figueroa; Kathleen C Flanders; Montserrat Garcia-Closas; William F Anderson; Xiaohong Rose Yang; Rayna K Matsuno; Máire A Duggan; Ruth M Pfeiffer; Akira Ooshima; Robert Cornelison; Gretchen L Gierach; Louise A Brinton; Jolanta Lissowska; Beata Peplonska; Lalage M Wakefield; Mark E Sherman
Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
Breast cancer research and treatment 2010;121(3):727-35.
2010: Hannah P Yang; Jesus Gonzalez Bosquet; Qizhai Li; Elizabeth A Platz; Louise A Brinton; Mark E Sherman; James V Lacey; Mia M. Gaudet; Laurie A Burdette; Jonine D Figueroa; Julia G Ciampa; Jolanta Lissowska; Beata Peplonska; STEPHEN CHANOCK; Montserrat Garcia-Closas
Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.
Carcinogenesis 2010;31(5):827-33.
2010: Mark Schiffman; Ana Cecilia Rodriguez; Zigui Chen; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Rob DeSalle; Brian Befano; Kai Yu; Mahboobeh Safaeian; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Diane Solomon; Philip E Castle; Robert D Burk
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.
Cancer research 2010;70(8):3159-69.
2010: Kelly L Bolton; Montserrat Garcia-Closas; Ruth M Pfeiffer; Máire A Duggan; William J Howat; Stephen M Hewitt; Xiaohong Rose Yang; Robert Cornelison; Sarah L Anzick; Paul Meltzer; Sean Davis; Petra Lenz; Jonine D Figueroa; Paul D P Pharoah; Mark E Sherman
Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(4):992-9.
2010: Mark E Sherman; Will Howatt; Fiona M Blows; Paul Pharoah; Stephen M Hewitt; Montserrat Garcia-Closas
Molecular pathology in epidemiologic studies: a primer on key considerations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(4):966-72.
2010: Sholom Wacholder; Patricia Hartge; Ross Prentice; Montserrat Garcia-Closas; Heather Spencer Feigelson; W Ryan Diver; Michael J Thun; David G Cox; Susan E Hankinson; Peter Kraft; Bernard Rosner; Christine D Berg; Louise A Brinton; Jolanta Lissowska; Mark E Sherman; Rowan Chlebowski; Charles Kooperberg; Rebecca D Jackson; Dennis W Buckman; Peter Hui; Ruth Pfeiffer; Kevin B Jacobs; Gilles D Thomas; Robert N Hoover; Mitchell H Gail; STEPHEN CHANOCK; David J Hunter
Performance of common genetic variants in breast-cancer risk models.
The New England journal of medicine 2010;362(11):986-93.
2010: Hannah P Yang; Louise A Brinton; Elizabeth A Platz; Jolanta Lissowska; James V Lacey; Mark E Sherman; Beata Peplonska; Montserrat Garcia-Closas
Active and passive cigarette smoking and the risk of endometrial cancer in Poland.
European journal of cancer (Oxford, England : 1990) 2010;46(4):690-6.
2010: Carolina Porras; Christina Bennett; Mahboobeh Safaeian; Sarah Coseo; Ana Cecilia Rodríguez; Paula González; Martha Hutchinson; Silvia Jiménez; Mark E Sherman; Sholom Wacholder; Diane Solomon; Leen-Jan van Doorn; Catherine Bougelet; Wim Quint; Mark Schiffman; Rolando Herrero; Allan Hildesheim
Determinants of seropositivity among HPV-16/18 DNA positive young women.
BMC infectious diseases 2010;10():238.
2010: Lisa Mirabello; Montserrat Garcia-Closas; Richard Cawthon; Jolanta Lissowska; Louise A Brinton; Beata Pepłońska; Mark E Sherman; Sharon A Savage
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study.
Cancer causes & control : CCC 2010;21(1):77-82.
2009: Nicolas Wentzensen; Rosemary E Zuna; Mark E Sherman; Michael A Gold; Mark Schiffman; S Terence Dunn; Jose Jeronimo; Roy Zhang; Joan Walker; Sophia S Wang
Accuracy of cervical specimens obtained for biomarker studies in women with CIN3.
Gynecologic oncology 2009;115(3):493-6.
2009: Nicolas Wentzensen; Mark Schiffman; Terence Dunn; Rosemary E Zuna; Michael A Gold; Richard A Allen; Roy Zhang; Mark E Sherman; Sholom Wacholder; Joan Walker; Sophia S Wang
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
International journal of cancer. Journal international du cancer 2009;125(9):2151-8.
2009: Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Allan Hildesheim; Diane Solomon; Mark E Sherman; Jose Jeronimo; Mario Alfaro; Jorge Morales; Diego Guillén; Martha L Hutchinson; Sholom Wacholder; Mark Schiffman
Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.
International journal of cancer. Journal international du cancer 2009;125(7):1649-56.
2009: Kristine ERICA Johnson; Mark E Sherman; Victor Ssempiija; Aaron A R Tobian; Jonathan M Zenilman; Maire A Duggan; Godfrey Kigozi; David Serwadda; Maria J Wawer; Thomas C Quinn; charles rabkin; Ronald H Gray
Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda.
AIDS (London, England) 2009;23(14):1807-15.
2009: Nicolas Wentzensen; Mark E Sherman; Mark Schiffman; Sophia S Wang
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.
Gynecologic oncology 2009;112(2):293-9.
2009: Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Mario Alfaro; Jorge Morales; Diego Guillen; Mark E Sherman; Diane Solomon; Mark Schiffman
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
BMJ (Clinical research ed.) 2009;339():b2569.
2009: Sophia S Wang; Rosemary E Zuna; Nicolas Wentzensen; S Terence Dunn; Mark E Sherman; Michael A Gold; Mark Schiffman; Sholom Wacholder; Richard A Allen; Ingrid Block; Kim Downing; Jose Jeronimo; J Daniel Carreon; Mahboobeh Safaeian; David Brown; Joan L Walker
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):113-20.
2009: Sophia S Wang; M Concepcion Bratti; Ana Cecilia Rodríguez; Rolando Herrero; Robert D Burk; Carolina Porras; Paula González; Mark E Sherman; Sholom Wacholder; Z Elizabeth Lan; Mark Schiffman; STEPHEN CHANOCK; Allan Hildesheim
Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.
The Journal of infectious diseases 2009;199(1):20-30.
2008: Louise A Brinton; Mark E Sherman; Joseph D Carreon; William F Anderson
Recent trends in breast cancer among younger women in the United States.
Journal of the National Cancer Institute 2008;100(22):1643-8.
2008: James V Lacey; George L Mutter; Marisa R Nucci; Brigitte M Ronnett; Olga B Ioffe; Brenda B Rush; Andrew G. Glass; Douglas A Richesson; Nilanjan Chatterjee; Bryan Langholz; Mark E Sherman
Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
Cancer 2008;113(8):2073-81.
2008: Roni T Falk; Elisabet Gentzschein; Frank Z Stanczyk; Louise A Brinton; Montserrat Garcia-Closas; Olga B Ioffe; Mark E Sherman
Measurement of sex steroid hormones in breast adipocytes: methods and implications.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(8):1891-5.
2008: James V Lacey; George L Mutter; Brigitte M Ronnett; Olga B Ioffe; Máire A Duggan; Brenda B Rush; Andrew G. Glass; Douglas A Richesson; Nilanjan Chatterjee; Bryan Langholz; Mark E Sherman
PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.
Cancer research 2008;68(14):6014-20.
2008: Melinda Butsch Kovacic; Hormuzd A Katki; Aimee R Kreimer; Mark E Sherman
Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections.
Human pathology 2008;39(7):1088-95.
2008: Sophia S Wang; Dominic J Smiraglia; Yue-Zhong Wu; Srimoyee Ghosh; Janet S Rader; Kathleen R Cho; Thomas A Bonfiglio; Ritu Nayar; Christoph Plass; Mark E Sherman
Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.
Cancer research 2008;68(7):2489-97.
2008: James V Lacey; Olga B Ioffe; Brigitte M Ronnett; Brenda B Rush; D A Richesson; Nilanjan Chatterjee; B Langholz; Andrew G. Glass; Mark E Sherman
Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.
British journal of cancer 2008;98(1):45-53.
2007: Patti Gravitt; Melinda Butsch Kovacic; Rolando Herrero; Mark Schiffman; Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Ana Cecilia Rodriguez; Robert D Burk
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
International journal of cancer. Journal international du cancer 2007;121(12):2787-93.
2007: Louise A Brinton; Lori Sakoda; Kirsten Frederiksen; Mark E Sherman; Susanne Krüger Kjaer; Barry I Graubard; Jørgen H Olsen; Lene Mellemkjaer
Relationships of uterine and ovarian tumors to pre-existing chronic conditions.
Gynecologic oncology 2007;107(3):487-94.
2007: Mark E Sherman; M Patricia Madigan; James V Lacey; Montserrat Garcia-Closas; Nancy Potischman; Joseph D Carreon; Patricia Hartge; Louise A Brinton
Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones.
Gynecologic oncology 2007;107(3):431-5.
2007: Xiaohong Rose Yang; Ruth M Pfeiffer; Montserrat Garcia-Closas; David L Rimm; Jolanta Lissowska; Louise A Brinton; Beata Peplonska; Stephen M Hewitt; Richard W Cartun; Daniza Mandich; Hironobu Sasano; Dean B Evans; Thomas R Sutter; Mark E Sherman
Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
Cancer research 2007;67(21):10608-17.
2007: Joseph D Carreon; Mark E Sherman; Diego Guillén; Diane Solomon; Rolando Herrero; Jose Jerónimo; Sholom Wacholder; Ana Cecilia Rodríguez; Jorge Morales; Martha Hutchinson; Robert D Burk; Mark Schiffman
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007;26(4):441-6.
2007: Patti Gravitt; Leen-Jan van Doorn; Wim Quint; Mark Schiffman; Allan Hildesheim; Andrew G. Glass; Brenda B Rush; Jared Hellman; Mark E Sherman; Robert D Burk; Sophia S Wang
Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.
Journal of clinical microbiology 2007;45(10):3245-50.
2007: Mark E Sherman; David L Rimm; Xiaohong Rose Yang; Nilanjan Chatterjee; Louise A Brinton; Jolanta Lissowska; Beata Peplonska; Neonila Szeszenia-Dabrowska; Witold Zatonski; Richard W Cartun; Daniza Mandich; Grzegorz Rymkiewicz; Marcin Ligaj; Stanislaw Lukaszek; Radzislaw Kordek; Zeynep Kalaylioglu; Malini Harigopal; Lori Charrette; Roni T Falk; Douglas Richesson; William F Anderson; Stephen M Hewitt; Montserrat García-Closas
Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis.
International journal of cancer. Journal international du cancer 2007;121(5):1079-85.
2007: Ana Cecilia Rodriguez; Robert D Burk; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillen; Mario Alfaro; Raphael P Viscidi; Jorge Morales; Martha Hutchinson; Sholom Wacholder; Mark Schiffman
The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life.
Sexually transmitted diseases 2007;34(7):494-502.
2007: Louise A Brinton; Lori Sakoda; Jolanta Lissowska; Mark E Sherman; Nilanjan Chatterjee; Beata Peplonska; N Szeszenia-Dabrowska; Witold Zatonski; Montserrat Garcia-Closas
Reproductive risk factors for endometrial cancer among Polish women.
British journal of cancer 2007;96(9):1450-6.
2007: William F Anderson; Rayna K Matsuno; Mark E Sherman; Jolanta Lissowska; Mitchell H Gail; Louise A Brinton; Xiaohong Rose Yang; Beata Peplonska; Bingshu E Chen; Philip S Rosenberg; Nilanjan Chatterjee; Neonila Szeszenia-Dabrowska; Alicja Bardin-Mikolajczak; Witold Zatonski; Susan S Devesa; Montserrat García-Closas
Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions.
Cancer causes & control : CCC 2007;18(4):439-47.
2007: Xiaohong Rose Yang; Mark E Sherman; David L Rimm; Jolanta Lissowska; Louise A Brinton; Beata Peplonska; Stephen M Hewitt; William F Anderson; Neonila Szeszenia-Dabrowska; Alicja Bardin-Mikolajczak; Witold Zatonski; Richard W Cartun; Daniza Mandich; Grzegorz Rymkiewicz; Marcin Ligaj; Stanislaw Lukaszek; Radzislaw Kordek; Montserrat García-Closas
Differences in risk factors for breast cancer molecular subtypes in a population-based study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):439-43.
2007: Mark E Sherman; Abhijit Dasgupta; Mark Schiffman; Ritu Nayar; Diane Solomon
The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology.
Cancer 2007;111(1):15-25.
2007: Montserrat Garcia-Closas; Louise A Brinton; Jolanta Lissowska; Douglas Richesson; Mark E Sherman; Neonila Szeszenia-Dabrowska; Beata Peplonska; Robert Welch; Meredith Yeager; Witold Zatonski; STEPHEN CHANOCK
Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study.
BMC cancer 2007;7():60.
2006: Mark E Sherman; Jessica Kahler; Karen S Gustafson; Sophia S Wang
"Sip volume" as a quality indicator in liquid-based cervical cytology.
Cancer 2006;108(6):462-7.
2006: James V Lacey; Michael F Leitzmann; Louise A Brinton; Jay H Lubin; Mark E Sherman; Arthur Schatzkin; Catherine Schairer
Weight, height, and body mass index and risk for ovarian cancer in a cohort study.
Annals of epidemiology 2006;16(12):869-76.
2006: Laila Adly; Deirdre Hill; Mark E Sherman; Susan R Sturgeon; Thomas R Fears; Carolyn Mies; Regina G Ziegler; Robert N Hoover; Catherine Schairer
Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
International journal of cancer. Journal international du cancer 2006;119(10):2402-7.
2006: Sue Kyung Park; Montserrat Garcia-Closas; Jolanta Lissowska; Mark E Sherman; Katherine A McGlynn; Beata Peplonska; Beata Pepońska; Alicja Bardin-Mikolajczak; Alicja Bardin-Mikoajczak; Witold Zatoński; Neonila Szeszenia-Dabrowska; Louise A Brinton
Intrauterine environment and breast cancer risk in a population-based case-control study in Poland.
International journal of cancer. Journal international du cancer 2006;119(9):2136-41.
2006: Sophia S Wang; Mark E Sherman; Steven G Silverberg; Joseph D Carreon; James V Lacey; Richard J Zaino; Robert J Kurman; Allan Hildesheim
Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study.
Gynecologic oncology 2006;103(2):541-6.
2006: Mark E Sherman; Philip E Castle; Diane Solomon
Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes.
Cancer 2006;108(5):298-305.
2006: Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana Cecilia Rodriguez; Martha L Hutchinson; M Concepcion Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.
Cancer research 2006;66(20):10112-9.
2006: Jolanta Lissowska; Louise A Brinton; Witold Zatonski; Aaron Blair; Alicja Bardin-Mikolajczak; Beata Peplonska; Mark E Sherman; Neonila Szeszenia-Dabrowska; STEPHEN CHANOCK; Montserrat García-Closas
Tobacco smoking, NAT2 acetylation genotype and breast cancer risk.
International journal of cancer. Journal international du cancer 2006;119(8):1961-9.
2006: William F Anderson; Ruth M Pfeiffer; Graça M Dores; Mark E Sherman
Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(10):1899-905.
2006: Xiaohong Rose Yang; Lori A Charette; Montserrat Garcia-Closas; Jolanta Lissowska; Edina Paal; Mary Sidawy; Stephen M Hewitt; David L Rimm; Mark E Sherman
Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2006;15(3):157-61.
2006: Sophia S Wang; Mark E Sherman; Janet S Rader; Joseph D Carreon; Mark Schiffman; Carl Baker
Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2006;15(3):144-8.
2006: Mark E Sherman; James V Lacey; Saundra S Buys; Douglas Reding; Christine D Berg; Craig Williams; Patricia Hartge
Ovarian volume: determinants and associations with cancer among postmenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(8):1550-4.
2006: Mia M. Gaudet; STEPHEN CHANOCK; Jolanta Lissowska; Sonja I Berndt; Xiaohong Rose Yang; Beata Peplonska; Louise A Brinton; Robert Welch; Meredith Yeager; Alicja Bardin-Mikolajczak; Mark E Sherman; Thomas R Sutter; Montserrat Garcia-Closas
Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
Pharmacogenetics and genomics 2006;16(8):547-53.
2006: Montserrat García-Closas; Louise A Brinton; Jolanta Lissowska; Nilanjan Chatterjee; Beata Peplonska; William F Anderson; Neonila Szeszenia-Dabrowska; Alicja Bardin-Mikolajczak; Witold Zatonski; Aaron Blair; Zeynep Kalaylioglu; Grzegorz Rymkiewicz; D Mazepa-Sikora; Radzislaw Kordek; Stanislaw Lukaszek; Mark E Sherman
Established breast cancer risk factors by clinically important tumour characteristics.
British journal of cancer 2006;95(1):123-9.
2006: Mark E Sherman; Joseph D Carreon; Mark Schiffman
Performance of cytology and human papillomavirus testing in relation to the menstrual cycle.
British journal of cancer 2006;94(11):1690-6.
2006: Jeffery Struewing; M A Pineda; Mark E Sherman; Jolanta Lissowska; Louise A Brinton; Beata Peplonska; Alicja Bardin-Mikolajczak; Montserrat Garcia-Closas
Skewed X chromosome inactivation and early-onset breast cancer.
Journal of medical genetics 2006;43(1):48-53.
2005: Louise A Brinton; Lori Sakoda; Mark E Sherman; Kirsten Frederiksen; Susanne Krüger Kjaer; Barry I Graubard; Jørgen H Olsen; Lene Mellemkjaer
Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(12):2929-35.
2005: Mark E Sherman; Joseph D Carreon; James V Lacey; Susan S Devesa
Impact of hysterectomy on endometrial carcinoma rates in the United States.
Journal of the National Cancer Institute 2005;97(22):1700-2.
2005: Joseph D Carreon; Maureen P Martin; Allan Hildesheim; Xiaojiang Gao; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Richard J Zaino; Mary Carrington; Sophia S Wang
Human leukocyte antigen class I and II haplotypes and risk of cervical cancer.
Tissue antigens 2005;66(4):321-4.
2005: Alice de M Zelmanowicz; Mark Schiffman; Rolando Herrero; Alisa M Goldstein; Mark E Sherman; Robert D Burk; Patti Gravitt; Raphael P Viscidi; Peter Schwartz; Willard A Barnes; Rodrigue Mortel; Steven G Silverberg; Julie Buckland; Allan Hildesheim
Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.
International journal of cancer. Journal international du cancer 2005;116(4):599-605.
2005: James V Lacey; Louise A Brinton; Jay H Lubin; Mark E Sherman; Arthur Schatzkin; Catherine Schairer
Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(7):1724-31.
2005: Catherine Schairer; Deirdre Hill; Susan R Sturgeon; Thomas R Fears; Carolyn Mies; Regina G Ziegler; Robert N Hoover; Mark E Sherman
Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(7):1660-5.
2005: Mark Schiffman; Rolando Herrero; Rob DeSalle; Allan Hildesheim; Sholom Wacholder; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Thomas C Wright; Diane Solomon; Zigui Chen; John E Schussler; Philip E Castle; Robert D Burk
The carcinogenicity of human papillomavirus types reflects viral evolution.
Virology 2005;337(1):76-84.
2005: Sophia S Wang; Abhijit Dasgupta; Mark E Sherman; Joan L Walker; Michael A Gold; Rosemary E Zuna; Lori Sakoda; Sholom Wacholder; Mark Schiffman; Carl Baker
Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2005;14(2):59-64.
2005: Philip E Castle; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Sholom Wacholder; Robert E Tarone; Robert D Burk
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.
The Journal of infectious diseases 2005;191(11):1808-16.
2005: Rolando Herrero; Philip E Castle; Mark Schiffman; M Concepcion Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Sabrina Chen; Ana Cecilia Rodriguez; Robert D Burk
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
The Journal of infectious diseases 2005;191(11):1796-807.
2005: Philip E Castle; Mark Schiffman; David R Scott; Mark E Sherman; Andrew G. Glass; Brenda B Rush; John E Schussler; Sholom Wacholder; Attila T Lorincz
Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1311-4.
2005: Mark E Sherman; Sophia S Wang; Joseph D Carreon; Susan S Devesa
Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
Cancer 2005;103(6):1258-64.
2004: Sophia S Wang; Mark Schiffman; Rolando Herrero; Joseph D Carreon; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Barbara Clayman; Robert D Burk; Raphael P Viscidi
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica.
British journal of cancer 2004;91(7):1269-74.
2004: Michelle D Althuis; Jennifer H Fergenbaum; Montserrat Garcia-Closas; Louise A Brinton; M Patricia Madigan; Mark E Sherman
Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(10):1558-68.
2004: Sophia S Wang; Marcus J Trunk; Mark Schiffman; Rolando Herrero; Mark E Sherman; Robert D Burk; Allan Hildesheim; M Concepcion Bratti; Tom Wright; Ana Cecilia Rodriguez; Sabrina Chen; Anja Reichert; Christina von Knebel Doeberitz; Ruediger Ridder; Magnus von Knebel Doeberitz
Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(8):1355-60.
2004: Mark E Sherman; Jules Berman; Michael J Birrer; Kathleen R Cho; Lora Hedrick Ellenson; Fred Gorstein; Jeffrey D Seidman
Current challenges and opportunities for research on borderline ovarian tumors.
Human pathology 2004;35(8):961-70.
2004: Philip E Castle; Mark Schiffman; M Concepcion Bratti; Allan Hildesheim; Rolando Herrero; Martha L Hutchinson; Ana Cecilia Rodriguez; Sholom Wacholder; Mark E Sherman; Hortense Kendall; Raphael P Viscidi; Jose Jeronimo; John E Schussler; Robert D Burk
A population-based study of vaginal human papillomavirus infection in hysterectomized women.
The Journal of infectious diseases 2004;190(3):458-67.
2004: William F Anderson; Kenneth C Chu; Shine Chang; Mark E Sherman
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(7):1128-35.
2004: Jennifer H Fergenbaum; Montserrat Garcia-Closas; Stephen M Hewitt; Jolanta Lissowska; Lori Sakoda; Mark E Sherman
Loss of antigenicity in stored sections of breast cancer tissue microarrays.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(4):667-72.
2004: James V Lacey; Nancy Potischman; M Patricia Madigan; Michael L Berman; Rodrigue Mortel; Leo B Twiggs; Rolland J Barrett; George D Wilbanks; John R Lurain; Capri-Mara Fillmore; Mark E Sherman; Louise A Brinton
Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(4):607-12.
2004: Mark E Sherman; Pamela J Mink; Rochelle Curtis; Timothy R Cote; Sandra Brooks; Patricia Hartge; Susan S Devesa
Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Cancer 2004;100(5):1045-52.
2004: Sophia S Wang; Mark E Sherman; Allan Hildesheim; James V Lacey; Susan S Devesa
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.
Cancer 2004;100(5):1035-44.
2004: Catherine Schairer; Deirdre Hill; Susan R Sturgeon; Thomas R Fears; Michael Pollak; Carolyn Mies; Regina G Ziegler; Robert N Hoover; Mark E Sherman
Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women.
International journal of cancer. Journal international du cancer 2004;108(5):773-9.
2004: M Concepcion Bratti; Ana Cecilia Rodríguez; Mark Schiffman; Allan Hildesheim; Jorge Morales; Mario Alfaro; Diego Guillén; Martha Hutchinson; Mark E Sherman; Claire Eklund; John E Schussler; Julie Buckland; Lidia Ana Morera; Fernando Cárdenas; Manuel Barrantes; Elmer Pérez; Thomas J Cox; Robert D Burk; Rolando Herrero
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.
Revista panamericana de salud pública = Pan American journal of public health 2004;15(2):75-89.
2004: Raphael P Viscidi; Mark Schiffman; Allan Hildesheim; Rolando Herrero; Philip E Castle; M Concepcion Bratti; Ana Cecilia Rodriguez; Mark E Sherman; Sophia Wang; Barbara Clayman; Robert D Burk
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(2):324-7.
2004: Tammy Shields; Roni T Falk; Rolando Herrero; Mark Schiffman; N S Weiss; Concepción Bratti; Ana Cecilia Rodriguez; Mark E Sherman; Robert D Burk; Allan Hildesheim
A case-control study of endogenous hormones and cervical cancer.
British journal of cancer 2004;90(1):146-52.
2004: James V Lacey; Mark E Sherman; Patricia Hartge; Arthur Schatzkin; Catherine Schairer
Medication use and risk of ovarian carcinoma: a prospective study.
International journal of cancer. Journal international du cancer 2004;108(2):281-6.
2004: Rochelle E Curtis; D Michal Freedman; Mark E Sherman; Joseph Fraumeni
Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer.
Journal of the National Cancer Institute 2004;96(1):70-4.
2003: Sophia S Wang; Mark Schiffman; Tammy Shields; Rolando Herrero; Allan Hildesheim; M Concepcion Bratti; Mark E Sherman; Ana Cecilia Rodriguez; Philip E Castle; Jorge Morales; Mario Alfaro; T Wright; S Chen; Barbara Clayman; Robert D Burk; Raphael P Viscidi
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica.
British journal of cancer 2003;89(7):1248-54.
2003: Mark E Sherman; Sophia S Wang; Cosette M Wheeler; Laurie Rich; Patti Gravitt; Robert E Tarone; Mark Schiffman
Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(10):1038-44.
2003: Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.
The American journal of pathology 2003;163(4):1405-16.
2003: Catterina Ferreccio; M Concepcion Bratti; Mark E Sherman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Robert D Burk; Martha Hutchinson; Mario Alfaro; Mitchell D Greenberg; Jorge Morales; Ana Cecilia Rodriguez; John E Schussler; Claire Eklund; Guillermo Marshall; Mark Schiffman
A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(9):815-23.
2003: Philip E Castle; Attila T Lorincz; David R Scott; Mark E Sherman; Andrew G. Glass; Brenda B Rush; Sholom Wacholder; Robert D Burk; M Michele Manos; John E Schussler; Paul Macomber; Mark Schiffman
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
Journal of clinical microbiology 2003;41(9):4022-30.
2003: Jose Jeronimo; Philip E Castle; Rolando Herrero; Mark E Sherman; M Concepcion Bratti; Allan Hildesheim; Mario Alfaro; Jorge Morales; Martha L Hutchinson; Robert D Burk; Attila Lorincz; Sholom Wacholder; Ana Cecilia Rodríguez; Mark Schiffman
Right-sided ectocervical lesions may be associated with false-negative cytology among women with histologic cervical intraepithelial neoplasia 2 or 3.
Journal of lower genital tract disease 2003;7(3):175-83.
2003: Mark E Sherman; Susan S Devesa
Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus.
Cancer 2003;98(1):176-86.
2003: Patti Gravitt; Robert D Burk; Attila T Lorincz; Rolando Herrero; Allan Hildesheim; Mark E Sherman; M Concepcion Bratti; Ana Cecilia Rodriguez; Kathy J Helzlsouer; Mark Schiffman
A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(6):477-84.
2003: Patti Gravitt; Allan Hildesheim; Rolando Herrero; Mark Schiffman; Mark E Sherman; M Concepcion Bratti; Ana Cecilia Rodriguez; Lidia Ana Morera; Fernando Cardenas; Frederick P Bowman; Keerti V Shah; Peggy A Crowley-Nowick
Correlates of IL-10 and IL-12 concentrations in cervical secretions.
Journal of clinical immunology 2003;23(3):175-83.
2003: Philip E Castle; Diane Solomon; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Ana Cecilia Rodriguez; Mario Alfaro; Martha L Hutchinson; S Terence Dunn; Jane Kuypers; Mark Schiffman
Stability of archived liquid-based cervical cytologic specimens.
Cancer 2003;99(2):89-96.
2003: Mark E Sherman; Sophia S Wang; Robert E Tarone; Laurie Rich; Mark Schiffman
Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(4):372-9.
2003: Mark E Sherman
Chapter 11: Future directions in cervical pathology.
Journal of the National Cancer Institute. Monographs 2003;(31):72-9.
2003: Mark E Sherman; Attila T Lorincz; David R Scott; Sholom Wacholder; Philip E Castle; Andrew G. Glass; Iwona Mielzynska-Lohnas; Brenda B Rush; Mark Schiffman
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Journal of the National Cancer Institute 2003;95(1):46-52.
2002: Pamela J Mink; Mark E Sherman; Susan S Devesa
Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998.
Cancer 2002;95(11):2380-9.
2002: Philip E Castle; Sholom Wacholder; Mark E Sherman; Attila T Lorincz; Andrew G. Glass; David R Scott; Brenda B Rush; Franklin Demuth; Mark Schiffman
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.
Cancer 2002;95(10):2145-51.
2002: Philip E Castle; Mark Schiffman; Robert D Burk; Sholom Wacholder; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila T Lorincz
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1394-9.
2002: Philip E Castle; Mark Schiffman; Patti Gravitt; Hortense Kendall; Stacy Fishman; Huali Dong; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila T Lorincz; John E Schussler; Robert D Burk
Comparisons of HPV DNA detection by MY09/11 PCR methods.
Journal of medical virology 2002;68(3):417-23.
2002: Philip E Castle; Sholom Wacholder; Attila T Lorincz; David R Scott; Mark E Sherman; Andrew G. Glass; Brenda B Rush; John E Schussler; Mark Schiffman
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
Journal of the National Cancer Institute 2002;94(18):1406-14.
2002: Sophia S Wang; Allan Hildesheim; Xiaojiang Gao; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Willard A Barnes; Mitchell D Greenberg; Larry McGowan; Rodrigue Mortel; Peter E Schwartz; Richard J Zaino; Andrew G. Glass; Robert D Burk; Peter Karacki; Mary Carrington
Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.
The Journal of infectious diseases 2002;186(5):598-605.
2002: Attila T Lorincz; Philip E Castle; Mark E Sherman; David R Scott; Andrew G. Glass; Sholom Wacholder; Brenda B Rush; Patti Gravitt; John E Schussler; Mark Schiffman
Viral load of human papillomavirus and risk of CIN3 or cervical cancer.
Lancet 2002;360(9328):228-9.
2002: James V Lacey; Pamela J Mink; Jay H Lubin; Mark E Sherman; Rebecca Troisi; Patricia Hartge; Arthur Schatzkin; Catherine Schairer
Menopausal hormone replacement therapy and risk of ovarian cancer.
JAMA : the journal of the American Medical Association 2002;288(3):334-41.
2002: Diana L Schneider; Louis Burke; Thomas C Wright; Mark Spitzer; Nilanjan Chatterjee; Sholom Wacholder; Rolando Herrero; M Concepcion Bratti; Mitchell D Greenberg; Allan Hildesheim; Mark E Sherman; Jorge Morales; Martha L Hutchinson; Mario Alfaro; Attila Lörincz; Mark Schiffman
Can cervicography be improved? An evaluation with arbitrated cervicography interpretations.
American journal of obstetrics and gynecology 2002;187(1):15-23.
2002: Sophia S Wang; Allan Hildesheim; Xiaojiang Gao; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Willard A Barnes; Mitchell D Greenberg; Larry McGowan; Rodrigue Mortel; Peter E Schwartz; Richard J Zaino; Andrew G. Glass; Robert D Burk; Peter Karacki; Mary Carrington
Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(4):419-20.
2002: Philip E Castle; Attila T Lorincz; Iwona Mielzynska-Lohnas; David R Scott; Andrew G. Glass; Mark E Sherman; John E Schussler; Mark Schiffman
Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible.
Journal of clinical microbiology 2002;40(3):1088-90.
2002: Philip E Castle; Tammy Shields; Reinhard Kirnbauer; M Michele Manos; Robert D Burk; Andrew G. Glass; David R Scott; Mark E Sherman; Mark Schiffman
Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.
Sexually transmitted diseases 2002;29(3):182-7.
2002: David R Scott; Bjorn Hagmar; Peter Maddox; Anders Hjerpe; Joakim Dillner; Jack Cuzick; Mark E Sherman; Mark H Stoler; Robert J Kurman; Nancy B Kiviat; M Michele Manos; Mark Schiffman
Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.
Cancer 2002;96(1):14-20.
2002: Mark E Sherman; Mark Schiffman; J Thomas Cox
Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).
Journal of the National Cancer Institute 2002;94(2):102-7.
2001: Sophia S Wang; Cosette M Wheeler; Allan Hildesheim; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Mario Alfaro; Martha L Hutchinson; Jorge Morales; Attila T Lorincz; Robert D Burk; Mary Carrington; Henry A Erlich; Raymond Apple
Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica.
The Journal of infectious diseases 2001;184(10):1310-4.
2001: Philip E Castle; S L Hillier; L K Rabe; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Robert D Burk; Ana Cecilia Rodriguez; Mario Alfaro; Martha L Hutchinson; Jorge Morales; Mark Schiffman
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(10):1021-7.
2001: Mark E Sherman; Diane Solomon; Mark Schiffman
Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study.
American journal of clinical pathology 2001;116(3):386-94.
2001: Philip E Castle; T R Zemlo; Robert D Burk; D R Scott; Mark E Sherman; Attila T Lorincz; Robert J Kurman; Andrew G. Glass; Brenda B Rush; K L Liaw; Mark Schiffman
Cervical HPV DNA detection as a predictor of a recurrent SIL diagnosis among untreated women.
Journal of lower genital tract disease 2001;5(3):138-43.
2001: Allan Hildesheim; Rolando Herrero; Philip E Castle; Sholom Wacholder; M Concepcion Bratti; Mark E Sherman; Attila T Lorincz; Robert D Burk; Jorge Morales; Ana Cecilia Rodriguez; K Helgesen; Mario Alfaro; Martha Hutchinson; I Balmaceda; M Greenberg; Mark Schiffman
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
British journal of cancer 2001;84(9):1219-26.
2001: Allan Hildesheim; Mark Schiffman; Christina M Bromley; Sholom Wacholder; Rolando Herrero; A Rodriguez; M Concepcion Bratti; Mark E Sherman; U Scarpidis; Q Q Lin; M Terai; R L Bromley; K Buetow; Raymond Apple; Robert D Burk
Human papillomavirus type 16 variants and risk of cervical cancer.
Journal of the National Cancer Institute 2001;93(4):315-8.
2001: KL Liaw; Allan Hildesheim; Robert D Burk; Patti Gravitt; Sholom Wacholder; M Michele Manos; David R Scott; Mark E Sherman; Robert J Kurman; Andrew G. Glass; S M Anderson; Mark Schiffman
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types.
The Journal of infectious diseases 2001;183(1):8-15.
2000: Patricia Hartge; Richard Hayes; Douglas Reding; Mark E Sherman; Philip C Prorok; Mark Schiffman; Saundra S Buys
Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial.
American journal of obstetrics and gynecology 2000;183(5):1232-7.
2000: A E Smith; Mark E Sherman; David R Scott; S O Tabbara; L Dworkin; J Olson; J Thompson; C Faser; J Snell; Mark Schiffman
Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears.
Cancer 2000;90(4):201-6.
2000: Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Martha Hutchinson; Jorge Morales; I Balmaceda; Mitchell D Greenberg; Mario Alfaro; Robert D Burk; Sholom Wacholder; M Plummer; Mark Schiffman
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.
Journal of the National Cancer Institute 2000;92(6):464-74.
2000: Mark E Sherman
Theories of endometrial carcinogenesis: a multidisciplinary approach.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2000;13(3):295-308.
2000: Mark Schiffman; Rolando Herrero; Allan Hildesheim; Mark E Sherman; M Concepcion Bratti; Sholom Wacholder; Mario Alfaro; Martha Hutchinson; Jorge Morales; Mitchell D Greenberg; Attila T Lorincz
HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
JAMA : the journal of the American Medical Association 2000;283(1):87-93.
1999: Louise Wideroff; Mark Schiffman; P Haderer; A Armstrong; CE Greer; M Michele Manos; Robert D Burk; David R Scott; Mark E Sherman; John T Schiller; R N Hoover; R E Tarone; Reinhard Kirnbauer
Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions.
The Journal of infectious diseases 1999;180(5):1424-8.
1999: Montserrat García-Closas; Rolando Herrero; Concepción Bratti; Allan Hildesheim; Mark E Sherman; Lidia Ana Morera; Mark Schiffman
Epidemiologic determinants of vaginal pH.
American journal of obstetrics and gynecology 1999;180(5):1060-6.
1999: Martha L Hutchinson; D J Zahniser; Mark E Sherman; Rolando Herrero; Mario Alfaro; M Concepcion Bratti; Allan Hildesheim; Attila T Lorincz; Mitchell D Greenberg; Jorge Morales; Mark Schiffman
Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.
Cancer 1999;87(2):48-55.
1999: Mark E Sherman; S O Tabbara; David R Scott; Robert J Kurman; Andrew G. Glass; M Michele Manos; Robert D Burk; Brenda B Rush; Mark Schiffman
"ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1999;12(4):335-42.
1999: Mark E Sherman; Jennifer Shuwen Lee; R T Burks; Jeffery Struewing; Robert J Kurman; Patricia Hartge
Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1999;18(2):151-7.
1999: A Ung; T R Kramer; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Robert D Burk; Christine A Swanson; Mark E Sherman; Martha L Hutchinson; Mario Alfaro; Jorge Morales; I Balmaceda; Allan Hildesheim
Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(3):249-53.
1999: D L Schneider; Rolando Herrero; Concepción Bratti; Mitchell D Greenberg; Allan Hildesheim; Mark E Sherman; Jorge Morales; Martha L Hutchinson; T V Sedlacek; Attila T Lorincz; LJ Mango; Sholom Wacholder; Mario Alfaro; Mark Schiffman
Cervicography screening for cervical cancer among 8460 women in a high-risk population.
American journal of obstetrics and gynecology 1999;180(2 Pt 1):290-8.
1998: Sana O Tabbara; MK Sidawy; Andra R Frost; Keith Brosky; V Coles; S Hecht; G Radcliffe; Mark E Sherman
The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides.
Cancer 1998;84(6):355-60.
1998: Mark E Sherman; Robert J Kurman
Intraepithelial carcinoma of the cervix: reflections on half a century of progress.
Cancer 1998;83(11):2243-6.
1998: Allan Hildesheim; Mark Schiffman; David R Scott; D Marti; T Kissner; Mark E Sherman; Andrew G. Glass; M Michele Manos; Attila T Lorincz; Robert J Kurman; J Buckland; Brenda B Rush; Mary Carrington
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(11):1035-41.
1998: Cheri L Peyton; Mark Schiffman; A T Lörincz; William C Hunt; I Mielzynska; Concepción Bratti; S Eaton; Allan Hildesheim; Lidia Ana Morera; Ana Cecilia Rodriguez; Rolando Herrero; Mark E Sherman; Cosette M Wheeler
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.
Journal of clinical microbiology 1998;36(11):3248-54.
1998: Mark E Sherman; Mark Schiffman; Rolando Herrero; Deidra Kelly; Concepción Bratti; LJ Mango; Mario Alfaro; Martha L Hutchinson; F Mena; Allan Hildesheim; Jorge Morales; Mitchell D Greenberg; I Balmaceda; Attila T Lorincz
Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
Cancer 1998;84(5):273-80.
1998: Mark E Sherman; M Mendoza; K R Lee; Raheela Ashfaq; G G Birdsong; M E Corkill; K M McIntosh; S L Inhorn; D J Zahniser; Gwen B Baber; C Barber; Mark H Stoler
Performance of liquid-based, thin-layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(9):837-43.
1998: Alice de M Zelmanowicz; Allan Hildesheim; Mark E Sherman; Susan R Sturgeon; Robert J Kurman; Rolland J Barrett; Michael L Berman; Rodrigue Mortel; Leo B Twiggs; George D Wilbanks; Louise A Brinton
Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors.
Gynecologic oncology 1998;69(3):253-7.
1998: S A Silver; Mark E Sherman
Morphologic and immunophenotypic characterization of foam cells in endometrial lesions.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1998;17(2):140-5.
1998: Susan R Sturgeon; Mark E Sherman; Robert J Kurman; Michael L Berman; Rodrigue Mortel; Leo B Twiggs; Rolland J Barrett; George D Wilbanks; Louise A Brinton
Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(3):231-5.
1998: Andra R Frost; MK Sidawy; M Ferfelli; Sana O Tabbara; N A Bronner; Keith Brosky; Mark E Sherman
Utility of thin-layer preparations in thyroid fine-needle aspiration: diagnostic accuracy, cytomorphology, and optimal sample preparation.
Cancer 1998;84(1):17-25.
1998: Louise Wideroff; Nancy Potischman; Andrew G. Glass; CE Greer; M Michele Manos; David R Scott; Robert D Burk; Mark E Sherman; Sholom Wacholder; Mark Schiffman
A nested case-control study of dietary factors and the risk of incident cytological abnormalities of the cervix.
Nutrition and cancer 1998;30(2):130-6.
1997: Mark E Sherman; Susan R Sturgeon; Louise A Brinton; N Potischman; Robert J Kurman; Michael L Berman; Rodrigue Mortel; Leo B Twiggs; Rolland J Barrett; George D Wilbanks
Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(10):963-8.
1997: Allan Hildesheim; Mark Schiffman; T Tsukui; Christine A Swanson; Joseph Lucci; David R Scott; Andrew G. Glass; Brenda B Rush; Attila T Lorincz; A Corrigan; Robert D Burk; K Helgesen; R A Houghten; Mark E Sherman; Robert J Kurman; J A Berzofsky; T R Kramer
Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(10):807-13.
1997: J U Cope; Allan Hildesheim; Mark Schiffman; M Michele Manos; A T Lörincz; Robert D Burk; Andrew G. Glass; C Greer; J Buckland; K Helgesen; David R Scott; Mark E Sherman; Robert J Kurman; KL Liaw
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.
Journal of clinical microbiology 1997;35(9):2262-5.
1997: Mark E Sherman; Mark Schiffman; LJ Mango; Deidra Kelly; D Acosta; zelma cason; P Elgert; S Zaleski; David R Scott; Robert J Kurman; M Stoler; Attila T Lorincz
Evaluation of PAPNET testing as an ancillary tool to clarify the status of the "atypical" cervical smear.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(6):564-71.
1997: Rolando Herrero; Mark Schiffman; Concepción Bratti; Allan Hildesheim; I Balmaceda; Mark E Sherman; M Greenberg; F Cárdenas; V Gómez; K Helgesen; Jorge Morales; Martha Hutchinson; LJ Mango; Mario Alfaro; N W Potischman; Sholom Wacholder; C Swanson; L A Brinton
Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project.
Revista panamericana de salud pública = Pan American journal of public health 1997;1(5):362-75.
1997: Mark E Sherman; Mark Schiffman; Attila T Lorincz; Rolando Herrero; Martha L Hutchinson; Concepción Bratti; D Zahniser; Jorge Morales; Allan Hildesheim; K Helgesen; Deidra Kelly; Mario Alfaro; F Mena; I Balmaceda; LJ Mango; M Greenberg
Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Cancer 1997;81(2):89-97.
1997: Howard D Strickler; Mark Schiffman; C Eklund; Andrew G. Glass; David R Scott; Mark E Sherman; Sholom Wacholder; Robert J Kurman; M Michele Manos; John T Schiller; Joakim Dillner
Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(3):183-8.
1996: Louise Wideroff; Mark Schiffman; Robert Hoover; R E Tarone; B Nonnenmacher; N Hubbert; Reinhard Kirnbauer; CE Greer; Attila T Lorincz; M Michele Manos; Andrew G. Glass; David R Scott; Mark E Sherman; J Buckland; Douglas Lowy; J Schiller
Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women.
The Journal of infectious diseases 1996;174(5):937-43.
1996: Mark E Sherman; Robert J Kurman
The role of exfoliative cytology and histopathology in screening and triage.
Obstetrics and gynecology clinics of North America 1996;23(3):641-55.
1996: S Hall; A Lörincz; F Shah; Mark E Sherman; FOUAD ABBAS; G Paull; Robert J Kurman; Keerti V Shah
Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
Gynecologic oncology 1996;62(3):353-9.
1995: Mark E Sherman; M E Bur; Robert J Kurman
p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.
Human pathology 1995;26(11):1268-74.
1995: David E Tunkel; Fuad M Baroody; Mark E Sherman
Fine-needle aspiration biopsy of cervicofacial masses in children.
Archives of otolaryngology--head & neck surgery 1995;121(5):533-6.
1995: Mark E Sherman; H B Friedman; A E Busseniers; W F Kelly; T C Carner; A J Saah
Cytologic diagnosis of anal intraepithelial neoplasia using smears and cytyc thin-preps.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1995;8(3):270-4.
1995: Mark Schiffman; N B Kiviat; Robert D Burk; Keerti V Shah; Richard W Daniel; R Lewis; Jane Kuypers; M Michele Manos; David R Scott; Mark E Sherman
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.
Journal of clinical microbiology 1995;33(3):545-50.
1995: Mark E Sherman; Susan R Sturgeon; Louise A Brinton; Robert J Kurman
Endometrial cancer chemoprevention: implications of diverse pathways of carcinogenesis.
Journal of cellular biochemistry. Supplement 1995;23():160-4.
1995: S A Silver; Ray Arthur; Yener S Erozan; Mark E Sherman; justin charles mcarthur; S Uematsu
Diagnosis of progressive multifocal leukoencephalopathy by stereotactic brain biopsy utilizing immunohistochemistry and the polymerase chain reaction.
Acta cytologica 1995;39(1):35-44.
1994: M Dieterich; Steven Goodman; R R Rojas-Corona; A B Emralino; D Jimenez-Joseph; Mark E Sherman
Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients.
Acta cytologica 1994;38(6):945-52.
1994: Mark E Sherman; Mark Schiffman; Attila T Lorincz; M Michele Manos; David R Scott; R J Kuman; N B Kiviat; M Stoler; Andrew G. Glass; Brenda B Rush
Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types.
American journal of clinical pathology 1994;102(2):182-7.
1994: Mark E Sherman; LJ Mango; Deidra Kelly; G Paull; V Ludin; C Copeland; D Solomon; Mark Schiffman
PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(5):578-81.
1994: Mark E Sherman; C Anderson; L M Herman; M E Ludwig; Yener S Erozan
Utility of gastric brushing in the diagnosis of malignant lymphoma.
Acta cytologica 1994;38(2):169-74.
1994: Allan Hildesheim; Mark Schiffman; Patti Gravitt; Andrew G. Glass; CE Greer; T Zhang; David R Scott; Brenda B Rush; P Lawler; Mark E Sherman
Persistence of type-specific human papillomavirus infection among cytologically normal women.
The Journal of infectious diseases 1994;169(2):235-40.
1994: Mark E Sherman; D Jimenez-Joseph; M D Gangi; R R Rojas-Corona
Immunostaining of small cytologic specimens. Facilitation with cell transfer.
Acta cytologica 1994;38(1):18-22.
1994: K J Wojno; J L Olson; Mark E Sherman
Cytopathology of pleural effusions after radiotherapy.
Acta cytologica 1994;38(1):1-8.
1994: Howard D Strickler; Joakim Dillner; Mark Schiffman; C Eklund; Andrew G. Glass; C Greer; David R Scott; Mark E Sherman; Robert J Kurman; M Michele Manos
A seroepidemiologic study of HPV infection and incident cervical squamous intraepithelial lesions.
Viral immunology 1994;7(4):169-77.
1993: R H Woods; David E Tunkel; Mark E Sherman
Pathologic quiz case 1. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
Archives of otolaryngology--head & neck surgery 1993;119(12):1378-80.
1993: Mark E Sherman; G Paull
Vaginal intraepithelial neoplasia. Reproducibility of pathologic diagnosis and correlation of smears and biopsies.
Acta cytologica 1993;37(5):699-704.
1993: Mark Schiffman; HM Bauer; Robert N Hoover; Andrew G. Glass; D M Cadell; Brenda B Rush; David R Scott; Mark E Sherman; Robert J Kurman; Sholom Wacholder
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
Journal of the National Cancer Institute 1993;85(12):958-64.
1993: Mark E Sherman; M Weinstein; M Sughayer; J O Cappellari; J E Orr; Yener S Erozan; M H Schiffman; Robert J Kurman
The Bethesda System. Impact on reporting cervicovaginal specimens and reproducibility of criteria for assessing endocervical sampling.
Acta cytologica 1993;37(1):55-60.
1992: David W Eisele; Mark E Sherman; Wayne M Koch; WJ Richtsmeier; A Y Wu; Yener S Erozan
Utility of immediate on-site cytopathological procurement and evaluation in fine needle aspiration biopsy of head and neck masses.
The Laryngoscope 1992;102(12 Pt 1):1328-30.
1992: Mark E Sherman; M H Schiffman; Yener S Erozan; S Wacholder; Robert J Kurman
The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses.
Archives of pathology & laboratory medicine 1992;116(11):1155-8.
1992: A Y Wu; Mark E Sherman; Neil B Rosenshein; Yener S Erozan
Pathologic evaluation of gynecologic specimens obtained with the cavitron ultrasonic surgical aspirator (CUSA).
Gynecologic oncology 1992;44(1):28-32.
1991: R L Starr; Mark E Sherman
The value of multiple preparations in the diagnosis of malignant pleural effusions. A cost-benefit analysis.
Acta cytologica 1991;35(5):533-7.
1991: Mark E Sherman; Yener S Erozan; Risa B Mann; A A Kumar; justin charles mcarthur; Walter III Royal; S Uematsu; H J Nauta
Stereotactic brain biopsy in the diagnosis of malignant lymphoma.
American journal of clinical pathology 1991;95(6):878-83.
1991: Mark E Sherman; J E Orr; K Balogh; R G Bardawil
Primary diagnosis of disseminated fungal disease by fine-needle aspiration of soft-tissue lesions.
Diagnostic cytopathology 1991;7(5):536-9.
1991: N A Dunsmore; Mark E Sherman; Yener S Erozan
Massive necrosis: a pitfall in the cytopathologic diagnosis of primary mediastinal seminoma.
Diagnostic cytopathology 1991;7(3):323-4.